Download presentation
Presentation is loading. Please wait.
1
Figure 1 Study flow chart.
From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22): doi: /eurheartj/ehx028 Eur Heart J | © The Author Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
2
Figure 2 Title: Left ventricular dysfunction without ischaemic heart disease: impact of primary prevention ICD on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22): doi: /eurheartj/ehx028 Eur Heart J | © The Author Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
3
Figure 3 (A) Title: Left ventricular dysfunction with ischaemic heart disease: impact of primary prevention ICD on all-cause mortality. (B). Title: Left ventricular dysfunction with ischaemic heart disease: impact of primary prevention ICD implanted during a dedicated procedure on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22): doi: /eurheartj/ehx028 Eur Heart J | © The Author Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
4
Figure 4 Left ventricular dysfunction with acute myocardial infarction: impact of primary prevention ICD on all-cause mortality. From: Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials Eur Heart J. 2017;38(22): doi: /eurheartj/ehx028 Eur Heart J | © The Author Published by Oxford University Press on behalf of the European Society of Cardiology.This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.